SCHEMBL8991939

SCHEMBL8991939

CC(C)(C)c1cc(CC=C2SCNC2=O)cc(C(C)(C)C)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.44
PTGS1 P23219 4/20 0.44
ALDH1A1 P00352 6/20 0.41
TSHR P16473 3/20 0.41
CYP1A2 P05177 3/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 2/20 0.41
BLM P54132 2/20 0.41
KMT2A Q03164 2/20 0.41
ATM Q13315 2/20 0.41
HIF1A Q16665 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
USP2 O75604 1/20 0.41
CYP2D6 P10635 1/20 0.41
GAA P10253 2/20 0.38
LMNA P02545 2/20 0.38
TDP1 Q9NUW8 2/20 0.37
CYP2C9 P11712 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9027935 1.00 PTGS2 (0.44) PTGS2PTGS1ALDH1A1TSHRCYP1A2
SCHEMBL3263476 0.80 PTGS2 (0.64) PTGS2PTGS1CYP1A2GAACYP2C9
SCHEMBL3263474 0.80 PTGS2 (0.64) PTGS2PTGS1CYP1A2GAACYP2C9
SCHEMBL8895700 0.75 ALDH1A1 (0.42) PTGS2PTGS1ALDH1A1TSHRCYP1A2
SCHEMBL8580718 0.74 MAPT (0.42) PTGS2PTGS1ALDH1A1TSHRCYP1A2
SCHEMBL9473753 0.73 PTGS2 (0.43) PTGS2PTGS1ALDH1A1CYP1A2HIF1A
SCHEMBL8536499 0.73 PTGS2 (0.55) PTGS2PTGS1ALDH1A1CYP1A2MAPT
SCHEMBL8536501 0.73 PTGS2 (0.55) PTGS2PTGS1ALDH1A1CYP1A2MAPT
SCHEMBL9029562 0.73 ALDH1A1 (0.40) PTGS2PTGS1ALDH1A1TSHRCYP1A2
SCHEMBL8933379 0.73 ALDH1A1 (0.40) PTGS2PTGS1ALDH1A1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
EP-0391644-B1 Aryl-substituted rhodanine derivatives LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5356917-A Antiischemic, antiinflammatory, antiarthritic agents, treat-ment of dystrophic mammals ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0391644-A2 Aryl-substituted rhodanine derivatives ELI LILLY AND COMPANY (US) 1990-10-10 EP disclosed